The average length of stay for malignant neoplasm of the bladder in hospitals in France is expected to decrease from 4.7 days in 2024 to 4.2 days by 2028. This indicates a continuous downward trend, with notable year-on-year decreases: 4.3% from 2024 to 2025, 2.2% from 2025 to 2026, 2.3% from 2026 to 2027, and 2.3% from 2027 to 2028. The compound annual growth rate (CAGR) over this five-year period projects a consistent decline, reflective of possible improvements in healthcare efficiency and early diagnoses.
Future trends to watch for include advancements in medical technology and treatment protocols that could further reduce hospital stays. Additionally, monitoring the integration of outpatient treatment options and post-discharge care programs will be vital in maintaining this downward trend.
